Lynch, V., McKeown, C., Mills, V., Armstrong, S., Rendall, J., Caskey, S., & Downey, D. (2022). 209 Metabolic changes after initiation of elexacaftor/tezacaftor/ivacaftor in a Northern Ireland population with cystic fibrosis. Journal of Cystic Fibrosis, 21, S123. https://doi.org/10.1016/s1569-1993(22)00899-2
Παραπομπή σε μορφή Chicago (17η εκδ.)Lynch, V., C. McKeown, V. Mills, S. Armstrong, J. Rendall, S. Caskey, και D. Downey. "209 Metabolic Changes After Initiation of Elexacaftor/tezacaftor/ivacaftor in a Northern Ireland Population with Cystic Fibrosis." Journal of Cystic Fibrosis 21 (2022): S123. https://doi.org/10.1016/s1569-1993(22)00899-2.
Παραπομπή σε μορφή MLA (9th εκδ.)Lynch, V., et al. "209 Metabolic Changes After Initiation of Elexacaftor/tezacaftor/ivacaftor in a Northern Ireland Population with Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 21, 2022, p. S123, https://doi.org/10.1016/s1569-1993(22)00899-2.